S
Scott M. Gordon
Researcher at University of Kentucky
Publications - 46
Citations - 1467
Scott M. Gordon is an academic researcher from University of Kentucky. The author has contributed to research in topics: Lipoprotein & Cholesterol. The author has an hindex of 20, co-authored 41 publications receiving 1175 citations. Previous affiliations of Scott M. Gordon include University of Cincinnati Academic Health Center & University of Cincinnati.
Papers
More filters
Journal ArticleDOI
Proteomic Characterization of Human Plasma High Density Lipoprotein Fractionated by Gel Filtration Chromatography
TL;DR: 14 new phospholipid-associated proteins that migrate with traditionally defined HDL are identified, several of which further support roles for HDL in complement regulation and protease inhibition.
Journal ArticleDOI
High density lipoprotein: it's not just about lipid transport anymore
TL;DR: Recent findings that point to important functions for HDL that go well beyond lipid transport suggest that HDL might be a platform that mediates protection from a host of disease states ranging from CVD to diabetes to infectious disease.
Journal ArticleDOI
The Changing Face of HDL and the Best Way to Measure It
TL;DR: The antioxidative, antiinflammatory, antiapoptotic, antithrombotic, antiinfective, and vasoprotective effects of HDL are all discussed, as are the related methodologies for assessing these different aspects of HDL function.
Journal ArticleDOI
A comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteins.
TL;DR: Mice have most of the minor proteins identified in human lipoproteins that play key roles in inflammation, innate immunity, proteolysis and its inhibition, and vitamin transport, which provides support for the continued use of the mouse as a model for many aspects of humanlipoprotein metabolism.
Journal ArticleDOI
High-Density Lipoprotein Maintains Skeletal Muscle Function by Modulating Cellular Respiration in Mice
Maarit Lehti,Elizabeth Donelan,William Abplanalp,Omar Al-Massadi,Kirk M. Habegger,Jon Weber,Chandler Ress,Johannes Mansfeld,Sonal Somvanshi,Chitrang Trivedi,Michaela Keuper,Teja Ograjsek,Cynthia Striese,Sebastian Cucuruz,Paul T. Pfluger,Radhakrishna Krishna,Scott M. Gordon,R. A. Gangani D. Silva,Serge Luquet,Julien Castel,Sarah Martinez,David A. D'Alessio,W. Sean Davidson,Susanna M. Hofmann +23 more
TL;DR: Findings indicate that HDL-raising therapies may preserve muscle mitochondrial function and address key aspects of type 2 diabetes mellitus beyond cardiovascular disease.